Literature DB >> 24790666

Is there a Role for Spect with (99m)Tc-Tetrofosmin in the Diagnostic Work Up of a Brain Tumor?

Theodossios Birbilis1, Nikolaos Boussios2, Lazaros Papatheodossiou1, Georgios Matis1, Athanassios Zissimopoulos2.   

Abstract

ABSTRACT: Brain MRI is the gold standard for diagnosis of brain tumors. In some cases preoperative MRI cannot predict the grade of malignancy, diagnostic information that could be very helpful to the surgeon. In such cases functional imaging with nuclear medicine techniques may prove quite useful.We present a case of a 58-year-old man with a brain tumor in the parieto-occipital region. Anatomic brain imaging by magnetic resonance imaging was indicative of a low grade astrocytoma. This was followed by planar imaging and single-photon emission computed tomography (SPECT) with (99m)Tc-tetrofosmin which showed increased radiotracer accumulation in the lesion, suggesting a glioblastoma which was histologically confirmed. We think that in the MRI era sometimes a (99m)Tc-tetrofosmin brain scan can contribute to diagnostic workup and improve the final management of the patient.

Entities:  

Keywords:  99mTc-tetrofosmin; SPECT; brain tumor; diagnosis

Year:  2013        PMID: 24790666      PMCID: PMC3968470     

Source DB:  PubMed          Journal:  Maedica (Buchar)        ISSN: 1841-9038


  12 in total

1.  The value of 99mTc-tetrofosmin brain SPECT in predicting survival in patients with glioblastoma multiforme.

Authors:  George A Alexiou; Spyridon Tsiouris; Athanasios P Kyritsis; George Fotakopoulos; Anna Goussia; Spyridon Voulgaris; Andreas D Fotopoulos
Journal:  J Nucl Med       Date:  2010-11-15       Impact factor: 10.057

2.  [Single-photon emission computed tomography in the evaluation of brain tumors and the diagnosis of relapse vs radiation necrosis].

Authors:  Georgios Alexiou; Spyridon Tsiouris; Andreas Fotopoulos
Journal:  Hell J Nucl Med       Date:  2007 Sep-Dec       Impact factor: 1.102

Review 3.  Positron emission tomography imaging of brain tumors.

Authors:  Terence Z Wong; Gert J van der Westhuizen; R Edward Coleman
Journal:  Neuroimaging Clin N Am       Date:  2002-11       Impact factor: 2.264

Review 4.  [99mTc]sestamibi and [99mTc]tetrofosmin in oncology: SPET and fusion imaging in lung cancer, malignant lymphomas and brain tumors.

Authors:  O Schillaci; A Spanu; G Madeddu
Journal:  Q J Nucl Med Mol Imaging       Date:  2005-06       Impact factor: 2.346

Review 5.  The role of scintigraphy in the evaluation of brain malignancies.

Authors:  Maria I Stathaki; Sophia I Koukouraki; Nikolaos S Karkavitsas
Journal:  Hell J Nucl Med       Date:  2010 Sep-Dec       Impact factor: 1.102

6.  Brain tumor imaging with 99mTc-tetrofosmin: comparison with 201Tl, 99mTc-MIBI, and 18F-fluorodeoxyglucose.

Authors:  J Y Choi; S E Kim; H J Shin; B T Kim; J H Kim
Journal:  J Neurooncol       Date:  2000       Impact factor: 4.130

7.  Spinal metastasis of glioblastoma multiforme: an uncommon suspect?

Authors:  Theodossios A Birbilis; Georgios K Matis; Savvas G Eleftheriadis; Efthimia N Theodoropoulou; Efthimios Sivridis
Journal:  Spine (Phila Pa 1976)       Date:  2010-04-01       Impact factor: 3.468

8.  Magnetic resonance perfusion and permeability imaging in brain tumors.

Authors:  Saulo Lacerda; Meng Law
Journal:  Neuroimaging Clin N Am       Date:  2009-11       Impact factor: 2.264

9.  [Value of thallium 201-SPECT in typing brain space-occupying lesions].

Authors:  M D Martínez del Valle Torres; M Gómez Rio; A Rodríguez Fernández; G Sabatel Hernandez; S Ortega Lozano; C Ramos Font; M Bellon Guardia; E López Ramírez; J M Llamas Elvira
Journal:  Rev Esp Med Nucl       Date:  2004 Sep-Oct

Review 10.  Imaging gliomas with positron emission tomography and single-photon emission computed tomography.

Authors:  François Bénard; Jonathan Romsa; Roland Hustinx
Journal:  Semin Nucl Med       Date:  2003-04       Impact factor: 4.446

View more
  1 in total

1.  99mTc-Tetrofosmin Uptake Correlates with the Sensitivity of Glioblastoma Cell Lines to Temozolomide.

Authors:  George A Alexiou; Xanthi Xourgia; Paraskevi Gerogianni; Evrysthenis Vartholomatos; John A Kalef-Ezra; Andreas D Fotopoulos; Athanasios P Kyritsis
Journal:  World J Nucl Med       Date:  2017 Jan-Mar
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.